A look at transactivation of the EGF receptor by angiotensin II

Journal of the American Society of Nephrology

Volumn 23, Issue 2, 2012, Pages 183-185

  Okada, Hirokazu ^a  

^a SAITAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; ANGIOTENSIN II; EPIDERMAL GROWTH FACTOR RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PROTEIN KINASE B; PROTEIN KINASE C; PROTEIN TYROSINE KINASE; TRANSFORMING GROWTH FACTOR BETA1; VIMENTIN;

ACUTE KIDNEY FAILURE; CELL MIGRATION; CHRONIC KIDNEY DISEASE; DISEASE COURSE; EDITORIAL; EPITHELIAL MESENCHYMAL TRANSITION; KIDNEY PROXIMAL TUBULE; MESANGIUM; NEPHRECTOMY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RENAL PROTECTION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; TRANSACTIVATION; TRANSGENE;

EID: 84856868405     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2011121178     Document Type: Editorial

References (20)

1. Wolf G: Novel aspects of the renin-angiotensin-aldosterone-system. Front Biosci 13: 4993-5005, 2008
2. Mehta PK, Griendling KK: Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system. AmJ Physiol Cell Physiol 292: C82-C97, 2007 (Pubitemid 46127306)
3. Rüster C, Wolf G: Angiotensin II as a morphogenic cytokine stimulating renal fibrogenesis. J Am Soc Nephrol 22: 1189-1199, 2011
4. Higuchi S,Ohtsu H, Suzuki H, Shirai H, Frank GD, Eguchi S: Angiotensin II signal transduction through the AT1 receptor: novel insights into mechanisms and pathophysiology. Clin Sci (Lond) 112: 417-428, 2007 (Pubitemid 46587457)
5. Zeng F, Singh AB, Harris RC: The role of the EGF family of ligands and receptors in renal development, physiology and pathophysiology. Exp Cell Res 315: 602-610, 2009
6. Terzi F, Burtin M, Hekmati M, Federici P, Grimber G, Briand P, Friedlander G: Targeted expression of a dominant-negative EGF-R in the kidney reduces tubulo-interstitial lesions after renal injury. J Clin Invest 106: 225-234, 2000 (Pubitemid 30483126)
7. Lautrette A, Li S, Alili R, Sunnarborg SW, Burtin M, Lee DC, Friedlander G, Terzi F: Angiotensin II and EGF receptor cross-talk in chronic kidney diseases: A new therapeutic approach. Nat Med 11: 867-874, 2005 (Pubitemid 41161119)
8. Chen J, Chen JK, Neilson EG, Harris RC: Role of EGF receptor activation in angiotensin II-induced renal epithelial cell hypertrophy. J Am Soc Nephrol 17: 1615-1623, 2006 (Pubitemid 43794664)
9. Wang Z, Chen JK, Wang SW, Moeckel G, Harris RC: Importance of functional EGF receptors in recovery from acute nephrotoxic injury. J Am Soc Nephrol 14: 3147-3154, 2003 (Pubitemid 37509292)
10. Sweeney WE Jr, Avner ED: Molecular and cellular pathophysiology of autosomal recessive polycystic kidney disease (ARPKD). Cell Tissue Res 326: 671-685, 2006
11. Wassef L, Kelly DJ, Gilbert RE: Epidermal growth factor receptor inhibition attenuates early kidney enlargement in experimental diabetes. Kidney Int 66: 1805-1814, 2004 (Pubitemid 41094304)
12. Gilbert RE, Huang Q, Thai K, Advani SL, Lee K, Yuen DA, Connelly KA, Advani A: Histone deacetylase inhibition attenuates diabetes-associated kidney growth: Potential role for epigeneticmodification of the epidermal growth factor receptor. Kidney Int 79: 1312-1321, 2011
13. Pillebout E, Weitzman JB, Burtin M, Martino C, Federici P, Yaniv M, Friedlander G, Terzi F: JunD protects against chronic kidney disease by regulating paracrine mitogens. J Clin Invest 112: 843-852, 2003 (Pubitemid 38063742)
14. Laouari D, Burtin M, Phelep A, Martino C, Pillebout E, Montagutelli X, Friedlander G, Terzi F: TGF-alphamediates genetic susceptibility to chronic kidney disease. J Am Soc Nephrol 22: 327-335, 2011
15. Chen J, Chen J-K, Nagai K, Plieth D, Tan M, Lee T-C, Threadgill DW, Neilson EG, Harris RC: EGFR signaling promotes TGFb-dependent renal fibrosis. J Am Soc Nephrol 23: 215-224, 2012
16. Zhuang S, Duan M, Yan Y: Src family kinases regulate renal epithelial dedifferentiation through activation of EGFR/PI3K signaling [published online ahead of print July 21, 2011].JCellPhysiol doi: 10.1002/jcp.22946
17. Kalluri R, Weinberg RA: The basics of epithelial-mesenchymal transition. J Clin Invest 119: 1420-1428, 2009
18. Galichon P, Hertig A: Epithelial to mesenchymal transition as a biomarker in renal fibrosis: Are we ready for the bedside? Fibrogenesis Tissue Repair 4: 11, 2011
19. Joo CK, Kim HS, Park JY, Seomun Y, Son MJ, Kim JT: Ligand releaseindependent transactivation of epidermal growth factor receptor by transforming growth factor-beta involves multiple signaling pathways. Oncogene 27: 614-628, 2008 (Pubitemid 351158894)
20. Iyoda M, Shibata T, Hirai Y, Kuno Y, Akizawa T: Nilotinib attenuates renal injury and prolongs survival in chronic kidney disease. J Am Soc Nephrol 22: 1486-1496, 2011